Wells Fargo’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $695M | Buy |
579,300
+66,600
| +13% | +$68M | 0.11% | 163 |
|
|
2026
Q1 | $472M | Sell |
512,700
-6,100
| -1% | -$6.18M | 0.09% | 212 |
|
|
2025
Q4 | $558M | Sell |
518,800
-134,900
| -21% | -$129M | 0.1% | 178 |
|
|
2025
Q3 | $499M | Buy |
653,700
+199,600
| +44% | +$149M | 0.09% | 185 |
|
|
2025
Q2 | $354M | Sell |
454,100
-32,000
| -7% | -$24.9M | 0.07% | 233 |
|
|
2025
Q1 | $401M | Sell |
486,100
-47,100
| -9% | -$39.2M | 0.09% | 207 |
|
|
2024
Q4 | $412M | Buy |
533,200
+89,100
| +20% | +$73.8M | 0.09% | 193 |
|
|
2024
Q3 | $393M | Buy |
444,100
+109,000
| +33% | +$98M | 0.09% | 203 |
|
|
2024
Q2 | $303M | Buy |
335,100
+41,400
| +14% | +$33.1M | 0.07% | 225 |
|
|
2024
Q1 | $228M | Buy |
293,700
+152,800
| +108% | +$109M | 0.06% | 281 |
|
|
2023
Q4 | $82.1M | Buy |
140,900
+132,200
| +1,520% | +$77.2M | 0.02% | 541 |
|
|
2023
Q3 | $4.67M | Sell |
8,700
-2,700
| -24% | -$1.39M | ﹤0.01% | 2159 |
|
|
2023
Q2 | $5.35M | Buy |
11,400
+3,600
| +46% | +$1.51M | ﹤0.01% | 2095 |
|
|
2023
Q1 | $2.68M | Buy |
7,800
+6,900
| +767% | +$2.33M | ﹤0.01% | 2631 |
|
|
2022
Q4 | $329K | Sell |
900
-9,100
| -91% | -$3.23M | ﹤0.01% | 3893 |
|
|
2022
Q3 | $3.23M | Buy |
+10,000
| New | +$3.17M | ﹤0.01% | 2333 |
|
|
2022
Q1 | – | Sell |
-39,600
| Closed | -$10.9M | – | 7491 |
|
|
2021
Q4 | $10.9M | Sell |
39,600
-62,800
| -61% | -$15.9M | ﹤0.01% | 1791 |
|
|
2021
Q3 | $23.7M | Buy |
102,400
+77,400
| +310% | +$19.1M | 0.01% | 1536 |
|
|
2021
Q2 | $5.74M | Buy |
+25,000
| New | +$5.02M | ﹤0.01% | 2739 |
|
|
2020
Q4 | – | Sell |
-5,000
| Closed | -$5K | – | 6779 |
|
|
2020
Q3 | $5K | Buy |
+5,000
| New | +$774K | ﹤0.01% | 6020 |
|
|
2018
Q2 | – | Sell |
-10,000
| Closed | -$42K | – | 6457 |
|
|
2018
Q1 | $42K | Hold |
10,000
| – | – | ﹤0.01% | 5619 |
|
|
2017
Q4 | $28K | Buy |
+10,000
| New | +$851K | ﹤0.01% | 5704 |
|
|
2017
Q1 | – | Sell |
-13
| Closed | -$2K | – | 6404 |
|
|
2016
Q4 | $2K | Buy |
+13
| New | +$968 | ﹤0.01% | 6095 |
|
|
2015
Q3 | – | Sell |
-400
| Closed | -$1K | – | 6329 |
|
|
2015
Q2 | $1K | Buy |
+400
| New | +$30.5K | ﹤0.01% | 6239 |
|
Other funds holding LLY
Wells Fargo's LLY Position: Q2 2026 in Review
Wells Fargo increased its Eli Lilly (LLY) stake by 5.5% in Q2 2026, buying an estimated $245M and bringing the position to 4,646,119 shares worth $5.57B. The position accounts for 0.9% of the portfolio, ranked #17.
Wells Fargo first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Wells Fargo held 4,646,119 shares of Eli Lilly worth $5.57B as of Q2 2026.
- Wells Fargo bought 240,275 Eli Lilly shares in Q2 2026, an estimated $245M.
- Eli Lilly made up 0.9% of Wells Fargo's portfolio in Q2 2026, its #17 holding.
- Wells Fargo first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.